Clinical Trial Update: Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating autologous endothelial progenitor cells from peripheral blood for treating critical limb ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Autologous Endothelial Progenitor Cells (EPCs) from peripheral blood

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Critical Limb Ischemia | Phase 1, Phase 2 | Status: COMPLETED